iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

Glaukos

Status: Terminated

Conditions: Primary Open Angle Glaucoma (POAG)

Treatments: Device: iStent inject surgery

Study type: Interventional

Funder types: Industry

Identifiers

NCT03478293

GCF-045

Details and patient eligibility

About

The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medications.

Full description

The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medications. Outcomes will be evaluated at 12 and 24 months.

Enrollment: 6 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Diagnosed with primary open angle glaucoma (POAG)
• Subject on two ocular hypotensive medications

Exclusion criteria

• Traumatic, uveitic, neovascular, or angle closure glaucoma
• Fellow eye already enrolled

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

6 participants in 1 patient group

iStent inject surgery

Experimental group

Description:

Single-arm study. Intervention is micro-invasive glaucoma surgery (MIGS) to implant iStent inject

Treatment:

Device: iStent inject surgery